Detailed Information on Publication Record
2019
Imaging of Bronchial Pathology in Antibody Deficiency: Data from the European Chest CT Group
SCHUTZ, Katharina, Diana ALECSANDRU, Bodo GRIMBACHER, Jamanda HADDOCK, Annemarie BRUINING et. al.Basic information
Original name
Imaging of Bronchial Pathology in Antibody Deficiency: Data from the European Chest CT Group
Authors
SCHUTZ, Katharina (276 Germany), Diana ALECSANDRU (826 United Kingdom of Great Britain and Northern Ireland), Bodo GRIMBACHER (276 Germany), Jamanda HADDOCK (826 United Kingdom of Great Britain and Northern Ireland), Annemarie BRUINING (528 Netherlands), Gertjan DRIESSEN (528 Netherlands), Esther DE VRIES (528 Netherlands), Peter M. VAN HAGEN, Ieneke HARTMANN (528 Netherlands), Francesco FRAIOLI (380 Italy), Cinzia MILITO (380 Italy), Milica MITREVSKI (380 Italy), Isabella QUINTI (380 Italy), Goffredo SERRA (380 Italy), Peter KELLEHER (826 United Kingdom of Great Britain and Northern Ireland), Michael LOEBINGER (826 United Kingdom of Great Britain and Northern Ireland), Jiří LITZMAN (203 Czech Republic, belonging to the institution), Věra POSTRÁNECKÁ (203 Czech Republic), Vojtěch THON (203 Czech Republic, guarantor, belonging to the institution), Judith BABAR (826 United Kingdom of Great Britain and Northern Ireland), Alison M. CONDLIFFE (826 United Kingdom of Great Britain and Northern Ireland), Andrew EXLEY (826 United Kingdom of Great Britain and Northern Ireland), Dinakantha KUMARARATNE (826 United Kingdom of Great Britain and Northern Ireland), Nick SCREATON (826 United Kingdom of Great Britain and Northern Ireland), Alison JONES (826 United Kingdom of Great Britain and Northern Ireland), Maria P. BONDIONI (380 Italy), Vassilios LOUGARIS (380 Italy), Alessandro PLEBANI (380 Italy), Annarosa SORESINA (380 Italy), Cesare SIRIGNANO (380 Italy), Giuseppe SPADARO (380 Italy), Nermeen GALAL (818 Egypt), Luis I. GONZALEZ-GRANADO (724 Spain), Sabine DETTMER (276 Germany), Robert STIRLING (36 Australia), Helen CHAPEL (826 United Kingdom of Great Britain and Northern Ireland), Mary LUCAS (826 United Kingdom of Great Britain and Northern Ireland), Smita PATEL (826 United Kingdom of Great Britain and Northern Ireland), Claire-Michele FARBER (56 Belgium), Isabelle MEYTS (56 Belgium), Arpan K. BANERJEE (826 United Kingdom of Great Britain and Northern Ireland), Scott HACKETT (826 United Kingdom of Great Britain and Northern Ireland), John R. HURST (826 United Kingdom of Great Britain and Northern Ireland), Klaus WARNATZ (276 Germany), Benjamin GATHMANN (276 Germany) and Ulrich BAUMANN (276 Germany)
Edition
Journal of Clinical Immunology, New York, Springer, 2019, 0271-9142
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30102 Immunology
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 6.780
RIV identification code
RIV/00216224:14110/19:00110433
Organization unit
Faculty of Medicine
UT WoS
000458867500011
Keywords in English
Chest CT; CVID; primary antibody deficiency; bronchiectasis; bronchial pathology
Tags
International impact, Reviewed
Změněno: 21/1/2020 07:03, Mgr. Tereza Miškechová
Abstract
V originále
Studies of chest computed tomography (CT) in patients with primary antibody deficiency syndromes (ADS) suggest a broad range of bronchial pathology. However, there are as yet no multicentre studies to assess the variety of bronchial pathology in this patient group. One of the underlying reasons is the lack of a consensus methodology, a prerequisite to jointly document chest CT findings. We aimed to establish an international platform for the evaluation of bronchial pathology as assessed by chest CT and to describe the range of bronchial pathologies in patients with antibody deficiency. Ffteen immunodeficiency centres from 9 countries evaluated chest CT scans of patients with ADS using a predefined list of potential findings including an extent score for bronchiectasis. Data of 282 patients with ADS were collected. Patients with common variable immunodeficiency disorders (CVID) comprised the largest subgroup (232 patients, 82.3%). Eighty percent of CVID patients had radiological evidence of bronchial pathology including bronchiectasis in 61%, bronchial wall thickening in 44% and mucus plugging in 29%. Bronchiectasis was detected in 44% of CVID patients aged less than 20years. Cough was a better predictor for bronchiectasis than spirometry values. Delay of diagnosis as well as duration of disease correlated positively with presence of bronchiectasis. The use of consensus diagnostic criteria and a pre-defined list of bronchial pathologies allows for comparison of chest CT data in multicentre studies. Our data suggest a high prevalence of bronchial pathology in CVID due to late diagnosis or duration of disease.
Links
EF15_003/0000469, research and development project |
|